Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Mar;31(3):874–878. doi: 10.1128/iai.31.3.874-878.1981

Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.

R Levy, E Segal, E Eylan
PMCID: PMC351400  PMID: 7014464

Abstract

Candida albicans ribosomes were prepared from mechanically disrupted cells through differential centrifugation and purification in a sucrose-ammonium sulfate solution. The ribosomes were analyzed chemically and physically and exhibited characteristics of eucaryotic ribosomes (78S). ICR female mice were immunized with two subcutaneous inoculations, 2 weeks apart, of 100 microgram of ribosomes (expressed as ribosomal protein). Immunized mice were challenged either intraperitoneally or intravenously with a lethal dose of live C. albicans cells. The 31-day survival rate of immunized mice challenged intraperitoneally was 64% (mean value) versus 27% in controls; in intravenously challenged mice the survival rate of the immunized animals was about 60%, with no survivors among the controls. In intravenously challenged mice, incomplete Freund adjuvant enhanced the protection elicited by the ribosomes. Protection by ribosomal immunization was obtained against challenge doses causing chronic and acute infection.

Full text

PDF
874

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Curry C. R., Quie P. G. Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med. 1971 Nov;285(22):1221–1225. doi: 10.1056/NEJM197111252852203. [DOI] [PubMed] [Google Scholar]
  3. Feit C., Tewari R. P. Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum. Infect Immun. 1974 Nov;10(5):1091–1097. doi: 10.1128/iai.10.5.1091-1097.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Field L. H., Parker C. D., Manclark C. R., Berry L. J. Evaluation of a ribosomal vaccine against pertussis. Infect Immun. 1979 May;24(2):346–351. doi: 10.1128/iai.24.2.346-351.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Giger D. K., Domer J. E., McQuitty J. T., Jr Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans. Infect Immun. 1978 Feb;19(2):499–509. doi: 10.1128/iai.19.2.499-509.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HASENCLEVER H. F., MITCHELL W. O. ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE. J Bacteriol. 1963 Sep;86:401–406. doi: 10.1128/jb.86.3.401-406.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hart P. D., Russell E., Jr, Remington J. S. The compromised host and infection. II. Deep fungal infection. J Infect Dis. 1969 Aug;120(2):169–191. doi: 10.1093/infdis/120.2.169. [DOI] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Leon L. L., Leon W., Chaves L., Costa S. C., Cruz M. Q., Brascher H. M., Lima A. O. Immunization of mice with Trypanosoma cruzi polyribosomes. Infect Immun. 1980 Jan;27(1):38–43. doi: 10.1128/iai.27.1.38-43.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lieberman M. M. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity. Infect Immun. 1978 Jul;21(1):76–86. doi: 10.1128/iai.21.1.76-86.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lynn M., Tewari R. P., Solotorovsky M. Immunoprotective activity of ribosomes from Haemophilus influenzae. Infect Immun. 1977 Feb;15(2):453–460. doi: 10.1128/iai.15.2.453-460.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  13. MOURAD S., FRIEDMAN L. Active immunization of mice against Candida albicans. Proc Soc Exp Biol Med. 1961 Mar;106:570–572. doi: 10.3181/00379727-106-26405. [DOI] [PubMed] [Google Scholar]
  14. MacMillan B. G., Law E. J., Holder I. A. Experience with Candida infections in the burn patient. Arch Surg. 1972 Apr;104(4):509–514. doi: 10.1001/archsurg.1972.04180040123021. [DOI] [PubMed] [Google Scholar]
  15. Michel F. B., Dussourd D'Hinterland L., Bousquet J., Pinel A. M., Normier G. Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans. Infect Immun. 1978 Jun;20(3):760–769. doi: 10.1128/iai.20.3.760-769.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Parker J. C., Jr, McCloskey J. J., Knauer K. A. Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host. Am J Clin Pathol. 1976 Jun;65(6):991–1000. doi: 10.1093/ajcp/65.6.991. [DOI] [PubMed] [Google Scholar]
  17. Rifkind D., Marchioro T. L., Schneck S. A., Hill R. B., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. doi: 10.1016/0002-9343(67)90146-5. [DOI] [PubMed] [Google Scholar]
  18. Riottot M., Fournier J. M., Pillot J. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun. 1979 May;24(2):476–482. doi: 10.1128/iai.24.2.476-482.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rubin G. M. Preparation of RNA and ribosomes from yeast. Methods Cell Biol. 1975;12:45–64. doi: 10.1016/s0091-679x(08)60951-6. [DOI] [PubMed] [Google Scholar]
  20. Schalla W. O., Johnson W. Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun. 1975 Jun;11(6):1195–1202. doi: 10.1128/iai.11.6.1195-1202.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Segal E., Eylan E. Genetic relatedness of Candida albicans to asporogenous and ascosporogenous yeasts as reflected by nucleic acid homologies. Microbios. 1974 Jan;9(33):25–33. [PubMed] [Google Scholar]
  22. Segal E., Levy R., Eylan E. Antibody formation in experimental immunizations with Candida albicans ribosomal fractions. Mycopathologia. 1978 Oct 16;64(2):121–123. doi: 10.1007/BF00440972. [DOI] [PubMed] [Google Scholar]
  23. Segal E., Osenholts M., Yankofsky S. A. Differentiation of 23-S ribosomal RNA cistrons from 16-S ribosomal RNA cistrons in Escherichia coli by the sequence complementarity test. Biochim Biophys Acta. 1973 Apr 21;308(7):79–87. doi: 10.1016/0005-2787(73)90124-x. [DOI] [PubMed] [Google Scholar]
  24. Soles P., Lim L. Y., Louria D. B. Active immunity in experimental candidiasis in mice. Sabouraudia. 1967 Jun;5(4):315–322. doi: 10.1080/00362176785190581. [DOI] [PubMed] [Google Scholar]
  25. TAYLOR M. M., STORCK R. UNIQUENESS OF BACTERIAL RIBOSOMES. Proc Natl Acad Sci U S A. 1964 Oct;52:958–965. doi: 10.1073/pnas.52.4.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tewari R. P., Sharma D., Solotorovsky M., Lafemina R., Balint J. Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infect Immun. 1977 Mar;15(3):789–795. doi: 10.1128/iai.15.3.789-795.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Venneman M. R., Bigley N. J., Berry L. J. Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium. Infect Immun. 1970 Jun;1(6):574–582. doi: 10.1128/iai.1.6.574-582.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Warner J. R. The assembly of ribosomes in yeast. J Biol Chem. 1971 Jan 25;246(2):447–454. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES